Reduced nasal viral load and IFN responses in infants with respiratory syncytial virus bronchiolitis and respiratory failure

American Journal of Respiratory and Critical Care Medicine

Volumn 198, Issue 8, 2018, Pages 1074-1084

  Thwaites, Ryan S ^a   Coates, Matthew ^b   Ito, Kazuhiro ^b   Ghazaly, Marwa ^c,d   Feather, Calandra ^c   Abdulla, Farhana ^c   Tunstall, Tanushree ^a   Jain, Pooja ^a   Cass, Lindsey ^b   Rapeport, Garth ^b   Hansel, Trevor T ^a   Nadel, Simon ^c   Openshaw, Peter ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b PULMOCIDE LTD   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d ASSIUT UNIVERSITY   (Egypt)

Author keywords

Innate immunity; Interferon; Nasosorption; Respiratory syncytial virus; Viral bronchiolitis

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 17; MUCIN 5AC; RANTES; CYTOKINE; TRANSCRIPTOME;

ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN METAPNEUMOVIRUS; INFANT; MALE; NASAL VIRAL LOAD; NASOPHARYNGEAL ASPIRATION; PEDIATRIC INTENSIVE CARE UNIT; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS; RHINOVIRUS; VIRAL BRONCHIOLITIS; VIRUS LOAD; VIRUS REPLICATION; IMMUNOLOGY; METABOLISM; NEWBORN; NOSE MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY;

BRONCHIOLITIS, VIRAL; CHEMOKINES; CYTOKINES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERONS; MALE; NASAL MUCOSA; RESPIRATORY INSUFFICIENCY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TRANSCRIPTOME; VIRAL LOAD;

EID: 85054888822     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201712-2567OC     Document Type: Article

References (48)

1. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006;368:312-322.
2. Tregoning JS, Schwarze J. Respiratory viral infections in infants: Causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010;23:74-98.
3. Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al.; RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: A systematic review and modelling study. Lancet 2017;390: 946-958.
4. Subhi R, Adamson M, Campbell H, Weber M, Smith K, Duke T; Hypoxaemia in Developing Countries Study Group. The prevalence of hypoxaemia among ill children in developing countries: A systematic review. Lancet Infect Dis 2009;9:219-227.
5. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 2003;143:S112-S117.
6. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126: 212-219.
7. Higgins D, Trujillo C, Keech C. Advances in RSV vaccine research and development: A global agenda. Vaccine 2016;34:2870-2875.
8. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014;134:e620-e638.
9. Openshaw PJ, Chiu C, Culley FJ, Johansson C. Protective and harmful immunity to respiratory syncytial virus infection. Annu Rev Immunol 2017;35:501-532.
10. Houben ML, Coenjaerts FE, Rossen JW, Belderbos ME, Hofland RW, Kimpen JL, et al. Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol 2010;82:1266-1271.
11. Franz A, Adams O, Willems R, Bonzel L, Neuhausen N, Schweizer-Krantz S, et al. Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 2010;48:239-245.
12. El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, Devincenzo JP. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis 2011; 204:996-1002.
13. DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis 2005;191:1861-1868.
14. Hasegawa K, Jartti T, Mansbach JM, Laham FR, Jewell AM, Espinola JA, et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: Multicenter cohort studies in the United States and Finland. J Infect Dis 2015;211:1550-1559.
15. DeVincenzo JP, Wilkinson T, Vaishnaw A, Cehelsky J, Meyers R, Nochur S, et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med 2010;182:1305-1314.
16. Openshaw PJ. The mouse model of respiratory syncytial virus disease. Curr Top Microbiol Immunol 2013;372:359-369.
17. Peebles RS Jr, Graham BS. Pathogenesis of respiratory syncytial virus infection in the murine model. Proc Am Thorac Soc 2005;2:110-115.
18. Faber TE, Groen H, Welfing M, Jansen KJ, Bont LJ. Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis. J Med Virol 2012;84:1084-1088.
19. McNamara PS, Flanagan BF, Hart CA, Smyth RL. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2005;191:1225-1232.
20. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child 2003;88:922-926.
21. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003;168:633-639.
22. Román M, Calhoun WJ, Hinton KL, Avendaño LF, Simon V, Escobar AM, et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997;156:190-195.
23. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001;184:393-399.
24. Nicholson EG, Schlegel C, Garofalo RP, Mehta R, Scheffler M, Mei M, et al. Robust cytokine and chemokine response in nasopharyngeal secretions: Association with decreased severity in children with physician diagnosed bronchiolitis. J Infect Dis 2016;214:649-655.
25. Thwaites RS, Ito K, Chingono JMS, Coates M, Jarvis HC, Tunstall T, et al. nasosorption as a minimally invasive sampling procedure: Mucosal viral load and inflammation in primary RSV bronchiolitis. J Infect Dis 2017;215:1240-1244.
26. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003;143: S118-S126.
27. Meerhoff TJ, Houben ML, Coenjaerts FE, Kimpen JL, Hofland RW, Schellevis F, et al. Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2010;29:365-371.
28. Macfarlane P, Denham J, Assous J, Hughes C. RSV testing in bronchiolitis: which nasal sampling method is best? Arch Dis Child 2005;90:634-635.
29. Chalom R, Raphaely RC, Costarino AT Jr. Hospital costs of pediatric intensive care. Crit Care Med 1999;27:2079-2085.
30. Scheltema NM, Gentile A, Lucion F, Nokes DJ, Munywoki PK, Madhi SA, et al.; PERCH Study Group. Global respiratory syncytial virusassociated mortality in young children (RSV GOLD): A retrospective case series. Lancet Glob Health 2017;5:e984-e991.
31. Pasanen A, Karjalainen MK, Bont L, Piippo-Savolainen E, Ruotsalainen M, Goksör E, et al. Genome-wide association study of polymorphisms predisposing to bronchiolitis. Sci Rep 2017;7:41653.
32. Plötz FB, Vreugdenhil HA, Slutsky AS, Zijlstra J, Heijnen CJ, van Vught H. Mechanical ventilation alters the immune response in children without lung pathology. Intensive Care Med 2002;28: 486-492.
33. McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 2015;523:612-616.
34. Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 2015;15:486-499.
35. Fuchs Y, Steller H. Live to die another way: Modes of programmed cell death and the signals emanating from dying cells. Nat Rev Mol Cell Biol 2015;16:329-344.
36. Zou J, Kawai T, Tsuchida T, Kozaki T, Tanaka H, Shin KS, et al. Poly IC triggers a cathepsin D- and IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis. Immunity 2013;38:717-728.
37. Valero-Pacheco N, Arriaga-Pizano L, Ferat-Osorio E, Mora-Velandia LM, Pastelin-Palacios R, Villasis-Keever MA, et al. PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell response. Clin Dev Immunol 2013;2013:989673.
38. Bi J, Tian Z. NK cell exhaustion. Front Immunol 2017;8:760.
39. Geerdink RJ, Pillay J, Meyaard L, Bont L. Neutrophils in respiratory syncytial virus infection: A target for asthma prevention. J Allergy Clin Immunol 2015;136:838-847.
40. Halfhide CP, Flanagan BF, Brearey SP, Hunt JA, Fonceca AM, McNamara PS, et al. Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis 2011;204:451-458.
41. Halfhide CP, Brearey SP, Flanagan BF, Hunt JA, Howarth D, Cummerson J, et al. Neutrophil TLR4 expression is reduced in the airways of infants with severe bronchiolitis. Thorax 2009;64:798-805.
42. Cortjens B, Ingelse SA, Calis JC, Vlaar AP, Koenderman L, Bem RA, et al. Neutrophil subset responses in infants with severe viral respiratory infection. Clin Immunol 2017;176:100-106.
43. Goritzka M, Makris S, Kausar F, Durant LR, Pereira C, Kumagai Y, et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med 2015;212:699-714.
44. Cole SL, Dunning J, Kok WL, Benam KH, Benlahrech A, Repapi E, et al. M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. JCI Insight 2017;2:e91868.
45. Rose MC, Nickola TJ, Voynow JA. Airway mucus obstruction: Mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am J Respir Cell Mol Biol 2001;25:533-537.
46. Fujisawa T, Velichko S, Thai P, Hung LY, Huang F, Wu R. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J Immunol 2009;183:6236-6243.
47. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 2004;78:4363-4369.
48. Schlender J, Hornung V, Finke S, Günthner-Biller M, Marozin S, Brzózka K, et al. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 2005;79:5507-5515.